Small molecule inhibits T-cell acute lymphoblastic leukaemia oncogenic interaction through conformational modulation of LMO2. (2020)
Attributed to:
Protein-Protein Interaction Inhibitors: From Design and Synthesis, Through Biophysics to Cell Permeable Inhibitors
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.27580
PubMed Identifier: 32477463
Publication URI: http://europepmc.org/abstract/MED/32477463
Type: Journal Article/Review
Volume: 11
Parent Publication: Oncotarget
Issue: 19
ISSN: 1949-2553